divalproex sodium

Generic: divalproex sodium

Labeler: upsher-smith laboratories, llc
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name divalproex sodium
Generic Name divalproex sodium
Labeler upsher-smith laboratories, llc
Dosage Form TABLET, DELAYED RELEASE
Routes
ORAL
Active Ingredients

divalproex sodium 250 mg/1

Manufacturer
Upsher-Smith Laboratories, LLC

Identifiers & Regulatory

Product NDC 0832-7123
Product ID 0832-7123_45afcbe0-c2e7-008a-e063-6394a90a111e
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA078182
Marketing Start 2014-03-21
Marketing End 2027-10-31

Pharmacologic Class

Classes
anti-epileptic agent [epc] decreased central nervous system disorganized electrical activity [pe] mood stabilizer [epc]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 08327123
Hyphenated Format 0832-7123

Supplemental Identifiers

RxCUI
1099625 1099678 1099870
UNII
644VL95AO6

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name divalproex sodium (source: ndc)
Generic Name divalproex sodium (source: ndc)
Application Number ANDA078182 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 250 mg/1
source: ndc
Packaging
  • 100 BLISTER PACK in 1 CARTON (0832-7123-01) / 1 TABLET, DELAYED RELEASE in 1 BLISTER PACK (0832-7123-89)
  • 100 TABLET, DELAYED RELEASE in 1 BOTTLE (0832-7123-11)
  • 500 TABLET, DELAYED RELEASE in 1 BOTTLE (0832-7123-15)
source: ndc

Packages (3)

Ingredients (1)

divalproex sodium (250 mg/1)

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "45afcbe0-c2e7-008a-e063-6394a90a111e", "openfda": {"unii": ["644VL95AO6"], "rxcui": ["1099625", "1099678", "1099870"], "spl_set_id": ["02304a23-4a5f-47bc-9687-4044b43f7a20"], "manufacturer_name": ["Upsher-Smith Laboratories, LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "100 BLISTER PACK in 1 CARTON (0832-7123-01)  / 1 TABLET, DELAYED RELEASE in 1 BLISTER PACK (0832-7123-89)", "package_ndc": "0832-7123-01", "marketing_end_date": "20270831", "marketing_start_date": "20160401"}, {"sample": false, "description": "100 TABLET, DELAYED RELEASE in 1 BOTTLE (0832-7123-11)", "package_ndc": "0832-7123-11", "marketing_end_date": "20270831", "marketing_start_date": "20140321"}, {"sample": false, "description": "500 TABLET, DELAYED RELEASE in 1 BOTTLE (0832-7123-15)", "package_ndc": "0832-7123-15", "marketing_end_date": "20270623", "marketing_start_date": "20140321"}], "brand_name": "Divalproex Sodium", "product_id": "0832-7123_45afcbe0-c2e7-008a-e063-6394a90a111e", "dosage_form": "TABLET, DELAYED RELEASE", "pharm_class": ["Anti-epileptic Agent [EPC]", "Decreased Central Nervous System Disorganized Electrical Activity [PE]", "Mood Stabilizer [EPC]"], "product_ndc": "0832-7123", "generic_name": "Divalproex Sodium", "labeler_name": "Upsher-Smith Laboratories, LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Divalproex Sodium", "active_ingredients": [{"name": "DIVALPROEX SODIUM", "strength": "250 mg/1"}], "application_number": "ANDA078182", "marketing_category": "ANDA", "marketing_end_date": "20271031", "marketing_start_date": "20140321"}